Sanara MedTech (SMTI) Net Margin (2010 - 2026)

Sanara MedTech has reported Net Margin for 16 years, with the latest figure at 0.22% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin rose 1262.0% year-over-year to 0.22%; the trailing twelve-month figure through Mar 2026 stood at 31.17% (down 1831.0% YoY), and the FY2025 full-year result was 36.05%, down 2685.0% from the prior year.
• Net Margin for Q1 2026 stood at 0.22%, up from 1.83% in the prior quarter.
• The five-year high for Net Margin was 0.22% in Q1 2026, with the low at 118.66% in Q3 2025.
• Historically, Net Margin has averaged 19.4% across 5 years, with a median of 11.27% in 2022.
• Annual changes were most pronounced in 2023 — Net Margin jumped 3223 bps — and 2025, when it sank 10619 bps.
• Sanara MedTech's Net Margin stood at 27.48% in 2022, then jumped by 95 bps to 1.48% in 2023, then tumbled by 575 bps to 10.02% in 2024, then surged by 82 bps to 1.83% in 2025, then surged by 112 bps to 0.22% in 2026.
• The last three Net Margin figures came in at 0.22% (Q1 2026), 1.83% (Q4 2025), and 118.66% (Q3 2025), per Business Quant data.